🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06344338
Recruiting Not applicable

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

NCT06344338 · tracked via the Priya Life Science China tracker
Sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Started
2024-04-01
Last updated
2026-08-04

Condition(s) studied

Refractory Status Epilepticus

Investigational drug(s) / intervention(s)

tDCS stimulationTDCS sham-stimulation

tDCS stimulation: In the real-stimulation group, Treatment was for 20 min, repeated twice in a day, then again over the next few days. The maximum number of stimuli required to terminate the status epilepticus should not exceed 10. In the sham-stimulation group, The duration and frequency of tDCS are the same as those in the treatment group, but the tDCS device is not active during the 20 minutes of sham-stimulation

TDCS sham-stimulation: TDCS sham-stimulation

Study summary

The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus

Eligibility

Sex
ALL
Min age
14 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 14 and 80 year-old with Gender unlimited, * Suitable for EEG monitoring; * Clinical diagnosis of Refractory status epilepticus (status epilepticus that cannot be controlled by two types of antiepileptic drugs and at least one anesthetic); * Informed consent to participate in this study was obtained from the participants or their surrogates Exclusion Criteria: * Unstable vital signs (systolic blood pressure\<90mmHg, heart rate\<60 beats/min, pulse oxygen saturation\<90%); * Having severe skull injury/defect or medical equipment implanted in the head; * Pregnancy; * With any implantable electronic instrument (including pacemakers, vagus nerve stimulators) or metal implanted devices.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xuanwu Hospital, Capital Medical University Beijing Beijing Municipality Recruiting

More Xuanwu Hospital, Beijing trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06344338 on ClinicalTrials.gov ↗ ← All trials in China